Cargando…
TFEC contributes to cardiac hypertrophy by inhibiting AMPK/mTOR signaling
The underlying mechanism of cardiac hypertrophy has not yet been fully elucidated. The present study aimed to explore the function of transcription factor EC (TFEC) in mouse models of cardiac hypertrophy and to determine the underlying mechanism. Pressure-overload cardiac hypertrophy and angiotensin...
Autores principales: | Zhao, Ting, Wang, Zhenyu, Chi, Yehong, Ni, Chunmei, Zheng, Xudan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456502/ https://www.ncbi.nlm.nih.gov/pubmed/34594408 http://dx.doi.org/10.3892/etm.2021.10706 |
Ejemplares similares
-
MSTN Attenuates Cardiac Hypertrophy through Inhibition of Excessive Cardiac Autophagy by Blocking AMPK /mTOR and miR-128/PPARγ/NF-κB
por: Qi, Hanping, et al.
Publicado: (2019) -
AMPK–mTOR Signaling and Cellular Adaptations in Hypoxia
por: Chun, Yoomi, et al.
Publicado: (2021) -
mTOR/PRAS40 interaction: Hypertrophy or proliferation
por: Völkers, Mirko, et al.
Publicado: (2013) -
Alpha-ketoglutarate extends Drosophila lifespan by inhibiting mTOR and activating AMPK
por: Su, Yuan, et al.
Publicado: (2019) -
KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy
por: Wang, Yi, et al.
Publicado: (2021)